(Q87923815)
Statements
Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel (English)
Jean-Pierre Droz
Jaques Medioni
Christine Chevreau
Helene De Mont-Serrat
Michael Merger
Peter Stopfer
Rolf Kaiser